We use cookies to provide you with a better service. Carry on browsing if you’re happy with this or read more about our cookie policy and privacy policy.
PHOENIX: Identification of biomarkers to predict response for emerging therapeutic agents for triple negative breast cancer. Utilising MRI.
I am an active member of the Patients Participation Group in Cirencester (Phoenix Health Group), and I have helped to create the annual wellness event